1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Category Archives: Immunosuppressive Drugs

26Mar/12

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium … – SYS-CON Media (press release)

March 26, 2012Immunosuppressive Drugsadmin

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium …SYS-CON Media (press release)… of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium (PtCr) Coronary Stent compared to the OMEGA™ Platinum Chromium Bare-Met…

25Mar/12

Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal … – SYS-CON Media (press release)

March 25, 2012Immunosuppressive Drugsadmin

Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal …SYS-CON Media (press release)In the US, the ION™ Paclitaxel-Eluting Stent System and the PROMUS Element Plus Everolimus-Eluting Stent System were approved by the Food and…

25Mar/12

Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal … – MarketWatch (press release)

March 25, 2012Immunosuppressive Drugsadmin

Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal …MarketWatch (press release)In the US, the ION(TM) Paclitaxel-Eluting Stent System and the PROMUS Element Plus Everolimus-Eluting Stent System were approved by the Food and …

23Mar/12

Dr. K: New medications treat pancreatic cancer – GoErie.com

March 23, 2012Immunosuppressive Drugsadmin

Dr. K: New medications treat pancreatic cancerGoErie.comThe two new drugs sunitinib (Sutent) and everolimus (Afinitor) are exciting alternatives to conventional chemotherapy. Sunitinib inhibits an enzyme critical to a complex chain of chemical events -…

23Mar/12

Everolimus DES: Stent-thrombosis advantage vs bare-metal stents in meta-analysis – TheHeart.Org

March 23, 2012Immunosuppressive Drugsadmin

MedPage TodayEverolimus DES: Stent-thrombosis advantage vs bare-metal stents in meta-analysisTheHeart.OrgLondon, UK – Drug-eluting stents (DES) should have a stent-thrombosis risk as low as possible, and compared with other types, cobalt-chromium evero…

23Mar/12

Everolimus plus exemestane improves bone health in post-menopausal women with … – RxPG NEWS

March 23, 2012Immunosuppressive Drugsadmin

Everolimus plus exemestane improves bone health in post-menopausal women with …RxPG NEWSBy ECCO-the European CanCer Organisation, [RxPG] Vienna, Austria: Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-men…

23Mar/12

Thrombosis Risk Lower with Xience Stent – MedPage Today

March 23, 2012Immunosuppressive Drugsadmin

MedPage TodayThrombosis Risk Lower with Xience StentMedPage TodayBy Todd Neale, Senior Staff Writer, MedPage Today This study found that in the first two years after implantation, cobalt-chromium everolimus-eluting stents (Xience) had lower rates of st…

23Mar/12

Combination of everolimus and exemestane reduces spread of cancer in the bone – News-Medical.net

March 23, 2012Immunosuppressive Drugsadmin

Combination of everolimus and exemestane reduces spread of cancer in the boneNews-Medical.netResults from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, ev…

23Mar/12

Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory … – News-Medical.net

March 23, 2012Immunosuppressive Drugsadmin

Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory …News-Medical.net"While standard anti-inflammatory treatment with inhaled corticosteroids helps many asthma patients, there is a significant number of patients who nee…

23Mar/12

Everolimus plus exemestane improves bone health in post-menopausal women with … – Medical Xpress

March 23, 2012Immunosuppressive Drugsadmin

Everolimus plus exemestane improves bone health in post-menopausal women with …Medical XpressResults from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, …

Posts navigation

  • « Previous
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 172
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos